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Abstract 
Background: Silica‑ε‑polycaprolactone‑nanoparticles (SiPCL‑NPs) represent a promising tool for laser‑tissue solder‑
ing in the brain. After release of the SiPCL‑NPs in the brain, neuronal differentiation might be modulated. The present 
study was performed to determine effects of SiPCL‑NP‑exposure at different stages of neuronal differentiation in 
neuron‑like SH‑SY5Y cells. The resulting phenotypes were analyzed quantitatively and signaling pathways involved 
in neuronal differentiation and degeneration were studied. SH‑SY5Y cells were differentiated with all‑trans retinoic 
acid or staurosporine to obtain predominantly cholinergic or dopaminergic neurons. The resulting phenotype was 
analyzed at the end of differentiation with and without the SiPCL‑NPs given at various times during differentiation.
Results: Exposure to SiPCL‑NPs before and during differentiation led to a decreased cell viability of SH‑SY5Y cells 
depending on the differentiation protocol used. SiPCL‑NPs co‑localized with the neuronal marker β‑3‑tubulin but did 
not alter the morphology of these cells. A significant decrease in the number of tyrosine hydroxylase (TH) immunore‑
active neurons was found in staurosporine‑differentiated cells when SiPCL‑NPs were added at the end of the differ‑
entiation. TH‑protein expression was also significantly downregulated when SiPCL‑NPs were applied in the middle of 
differentiation. Protein expression of the marker for the dopamine active transporter (DAT) was not affected by SiPCL‑
NPs. SiPCL‑NP‑exposure predominantly decreased the expression of the high‑affinity choline transporter 1 (CHT1) 
when the NPs were given before the differentiation. Pathways involved in neuronal differentiation, namely Akt, MAP‑K, 
MAP‑2 and the neurodegeneration‑related markers β‑catenin and GSK‑3β were not altered by NP‑exposure.
Conclusions: The decrease in the number of dopaminergic and cholinergic cells may implicate neuronal dysfunc‑
tion, but the data do not provide evidence that pathways relevant for differentiation and related to neurodegenera‑
tion are impaired.
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Background
Nanomaterials are used in medical applications includ-
ing drug delivery in the central nervous system (CNS) 
[1]. Recently, biodegradable scaffolds with silica-ε-
polycaprolactone-nanoparticles (SiPCL-NPs), bovine 
serum albumin (BSA) and indocyanine green have been 
developed for suture-less tissue fusion, namely laser-tis-
sue soldering (LTS). LTS provides a promising alternative 
treatment method for injuries of blood vessels, offer-
ing shorter procedure time, immediate water tightness, 
faster wound healing and reduced recovery time as com-
pared to classical microsuturing [2–4]. This technique 
makes use of a degradable polymer scaffold containing 
albumin and the chromophore indocyanine green (ICG). 
Tissue fusion is achieved by laser irradiation that results 
in denaturation of the BSA [5–7]. The breakdown of 
biodegradable implant leads to NP-release into the sur-
rounding tissue. Therefore, interactions of nanomateri-
als with neurons and other cells in the brain need to be 
studied to estimate the possible health hazards. Intra-
nasal administration of silica nanoparticles (Si-NPs) in 
rats was reported to induce oxidative stress and apopto-
sis in the striatum [8] and increase apoptotic cell death 
in hypothalamic neuronal cells (GT1) [9]. Similarly, oxi-
dative damage and increased inflammation were found 
in the striatum of rats after intranasal application of Si-
NPs. In vitro studies revealed a decrease in cell viability, 
an induction of oxidative stress, apoptosis and a deple-
tion of dopamine accompanied by a decrease of tyrosine 
hydroxylase (TH) in the striatum as well as a in PC12 
cells [10]. On the other hand, although oral administra-
tion of Si-NPs in Drosophila melanogaster resulted in an 
uptake into larval and adult neuronal tissues, neuronal 
cell viability was not affected [11]. Uptake of SiPCL-NPs 
designed for laser-tissue soldering [5, 6] has been dem-
onstrated for microglia and neuron-like SH-SY5Y cells. 
SiPCL-NPs did not affect cell viability, cytotoxicity and 
apoptosis but led to a depletion of glutathione indicat-
ing oxidative stress [12]. The same NPs did not induce 
inflammation and autophagy in microglial cells [13] but 
impaired mitochondrial function in SH-SY5Y cells [14]. 
Notably, Si-NPs were shown to increase the production 
of reactive oxygen species and reactive nitrogen species 
in primary microglial cells [15], similarly to effects shown 
with silver nanoparticles (AgNPs) [16]. As mitochondrial 
dysfunction and oxidative stress have been demonstrated 
to play an important role in the development of neuro-
degenerative diseases [17, 18], and if NPs compromise 
neuronal differentiation and related signaling pathways 
[19–21], they pose a risk for neurodegeneration. Dayem 
et al. [22] demonstrated an increase in neurite length and 
an enhanced expression of neuronal differentiation mark-
ers after AgNP-exposure in SH-SY5Y cells. In contrast, 
neurite outgrowth was not modulated by SiPCL-NP-
exposure in SH-SY5Y cells but led to a reduction of neu-
ronal differentiation [23]. Zinc oxide NPs (ZnONPs) were 
reported to induce MAP-K/ERK phosphorylation in pri-
mary astrocytes [24]. In contrast, SiPCL-NP were shown 
to moderately decrease phosphorylated MAP-K in neu-
ron-like SH-SY5Y cells [23]. Qiao et al. demonstrated an 
inhibition of PI3K/Akt, a pathway known to be involved 
in neuronal differentiation [14], neuronal survival [25] 
and neurogenesis [26], leading to a complete inhibition of 
neuronal differentiation [27]. In PC12 cells, SiNPs were 
shown to suppress phosphorylation of PI3K and Akt 
[28]. On the other hand, AgNP- and SiPCL-NP-exposure 
were demonstrated to upregulate phosphorylated Akt 
in SH-SY5Y cells [14, 22]. The Wnt/β-catenin-pathway 
is involved in the development and maintenance of the 
nervous system [29]. Activation of this pathway was 
reported to prevent neuronal death [17, 30], while a 
decrease in Wnt-signaling is related to the pathogenesis 
of neurodegeneration [31, 32]. In line with this notion, 
titanium dioxide NPs  (TiO2NPs) have been demonstrated 
to significantly decrease the expression of markers of the 
Wnt-pathway [33].
Alterations of the dopaminergic phenotype may pose 
a threat towards neurodegeneration especially in Parkin-
son’s disease [34]. As cells undergo complex morphologi-
cal, biochemical and functional shifts [35], NP-exposure 
needs to be studied at various times during differentia-
tion. In this study, neuronal differentiation, consequential 
cellular phenotypes and the underlying signaling path-
ways [17, 26, 31] were investigated after SiPCL-NP-expo-
sure using various differentiation protocols.
Results
Viability of differentiated SH‑SY5Y cells 
after NP‑administration
Effects of SiPCL-NPs designed for LTS in the brain 
[5–7, 36] were studied in SH-SY5Y cells during neu-
ronal differentiation. SiPCL-NPs at a concentration of 
2.6 × 1010 NPs/ml (24.9  μg/ml) significantly decreased 
the cell viability in all-trans retinoic acid (RA)- and 
staurosporine (ST)-differentiated SH-SY5Y cells with 
the effect depending on the specific timing of the 
exposure and the differentiation-supplement used 
(Fig. 1a–c). Cell viability was significantly reduced after 
SiPCL-NP-incubation at day in vitro (DIV) 1 in undif-
ferentiated, RA-differentiated and ST-treated cells, 
respectively with the effect being more pronounced in 
RA-treated cells (Fig. 1a). SiPCL-NP-administration at 
DIV4 diminished the viability of ST-differentiated cells 
significantly, whereas no reduction was found in RA-
treated cells. NP-exposure significantly reduced the cell 
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viability in undifferentiated cells when given at DIV4 
but not at DIV6 (Fig. 1b–c). Significant changes in cell 
viability were found when SiPCL-NPs were exposed at 
DIV6 regardless of the differentiation supplement used 
(Fig. 1c).
Morphology of differentiated SH‑SY5Y cells
Naïve undifferentiated SH-SY5Y cells grew in clusters 
and the cell bodies appeared globular with only short 
neuronal processes in control cells (Fig.  2A) as well as 
after SiPCL-NP-exposure at DIV1, DIV4 and DIV6 
(Fig.  2B–D). RA- (Fig.  2E–H) and ST-differentiated 
(Fig.  2I–L) SH-SY5Y cells showed longer processes that 
interconnected and formed a network. Incubation with 
rhodamine-labeled SiPCL-NPs showed that the NPs were 
located close to the nuclei, and they co-localized with 
the neuronal marker β-3-tubulin. NPs did not cause any 
obvious changes in cell morphology (Fig.  2B–D, F–H, 
J–L) or the expression of α/β-synuclein (data not shown).
Quantitative analyses of the cellular phenotype
Semi-quantitative analyses showed an increased number 
of tyrosine hydroxylase (TH)-positive cells in ST-differ-
entiated cells (15%) with the effect being similar to previ-
ously published findings [37, 38]. In contrast, RA did not 
increase TH-immunoreactive (-ir) cells when compared 
to undifferentiated cells (Fig. 3A–C). SiPCL-NP-exposure 
at DIV1 did not change the number of TH-ir cells in any 
of the tested conditions (undifferentiated cells, RA- and 
ST-treated cells) (Fig.  3A). A significant decrease in the 
number of TH-ir cells was observed when the SiPCL-NP-
exposure was performed at DIV4 in RA-differentiated 
cells (Fig. 3B). A more prominent decrease in TH-ir cells 
was found in ST-differentiated cells after NP-application 
at DIV6 (Fig. 3C). TH-staining was barely detectable nei-
ther in undifferentiated cells (Fig. 3D) nor in RA-differen-
tiated SH-SY5Y cells exposed to NPs at DIV4 (Fig. 3E). In 
contrast, TH was strongly expressed in ST-differentiated 
cells with the signal also being present in the neuronal 
processes (Fig.  3F). About 15% CHT1-immunoreactive 
(ir) cells were found in undifferentiated cells (Fig. 4A–C). 
ST-supplementation significantly reduced the number of 
CHT1-ir cells when compared to undifferentiated control 
cells (Fig. 4A). SiPCL-NP-exposure at DIV1 resulted in a 
significant decrease in the number of CHT1 cells at the 
end of differentiation regardless of the condition investi-
gated, namely undifferentiated, RA- and ST-differentiated 
cells (Fig. 4A). A significantly lower number of CHT1-ir 
cells was found following NP-exposure at DIV4 in the 
RA-differentiated group (Fig. 4B). The number of CHT1-
ir cells increased significantly when the cells were differ-
entiated with RA compared to undifferentiated control 
cells (Fig. 4B). NP-treatment at DIV6 had no effect on the 
CHT1-ir cell number in any conditions tested (Fig. 4C). 
In the respective immunofluorescence images, the CHT1 
signal was localized close to the nuclei and it showed a 
vesicular pattern (Fig. 4D–F). After SiPCL-NP exposure, 
high-affinity choline transporter 1 (CHT1)-ir cells were 
Fig. 1 SH‑SY5Y cells were differentiated with retinoic acid (RA) or 
staurosporine (ST). Undifferentiated cells were grown in parallel. 
SiPCL‑NP‑exposure was performed at a concentration of (2.6 × 1010 
NPs/ml) for 24 h at day in vitro (DIV) 1 (a), DIV4 (b) or DIV6 (c). Cell 
viability was analyzed on DIV7 in undifferentiated and differentiated 
cells. The data represents the mean percentage (%) of the cell viability 
in relation to the respective controls. Error bars correspond to SEM. 
Significant differences between control‑ and NP‑exposed‑groups 
are labeled with asterisks (*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; 
****p ≤ 0.0001)
Page 4 of 15Wiedmer et al. J Nanobiotechnol           (2019) 17:46 
most prominent in RA-differentiated cells (Fig. 4E) when 
compared to undifferentiated cells (Fig. 4D) and ST-dif-
ferentiated cells (Fig. 4F).
Expression of phenotypical markers
TH, the rate limiting enzyme in dopamine-synthesis, 
was significantly upregulated in ST-differentiated SH-
SY5Y cells (10-fold) compared to undifferentiated and 
RA-treated SH-SY5Y cells (Fig. 5b). SiPCL-NP-exposure 
significantly decreased the expression of TH when dif-
ferentiated with ST (Fig.  5b). SiPCL-NP-exposure at 
DIV1 (Fig. 5a) and DIV6 (Fig. 5c) resulted in a significant 
increase in TH-expression (15- to 20-fold) in ST-treated 
SH-SY5Y cells when compared to undifferentiated and 
RA-treated SH-SY5Y cells with or without NP-expo-
sure at DIV1 (Fig. 5b). A 10- to 15-fold increase in TH-
expression was found in control cells differentiated with 
ST at DIV6 (Fig.  5c). TH-expression was significantly 
higher after SiPCL-NP-exposure at DIV1 and DIV6 in 
ST-treated SH-SY5Y cells. The dopaminergic marker, 
dopamine active transporter (DAT), was not significantly 
altered regardless of the differentiation supplement and 
the time of NP-exposure (Fig.  5d, e). SiPCL-NP-expo-
sure on DIV1 (Fig.  5f ) resulted in a significant increase 
in CHT1-expression in RA-treated SH-SY5Y cells 
compared the respective RA-control, undifferentiated 
Fig. 2 Representative immunofluorescence microscopy images showing the morphology of SH‑SY5Y cells on day in vitro (DIV) 7, stained with 
b‑3‑tubulin (green). Cells were kept undifferentiated (A–D), differentiated with retinoic acid (RA) (E–H) or staurosporine (ST) (I–L). Control images, 
unexposed to NPs, are shown in A, B and C. SH‑SY5Y cells exposed to (2.6 × 1010 NPs/ml) SiPCL‑NPs (red) for 24 h at DIV1 are depicted in B, F and J. 
SH‑SY5Y cells exposed to NPs at DIV4 are shown in C, G and K and exposure at DIV6 in D, H and L. Nuclei are shown in blue. Magnification ×630, 
scale bar = 50 μm
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controls and undifferentiated-NP-exposed cells. ST-
treated naïve and NP-exposed SH-SY5Y cells showed a 
significantly increased CHT1-expression when compared 
to RA-differentiated control cells and RA-differentiated 
NP-exposed cells (Fig. 5f ). The expression of CHT1 was 
not significantly altered after differentiation with or with-
out NPs at DIV4 or DIV6 when RA- or ST-differentiated 
cells were compared to undifferentiated cells (Fig.  5g, 
h). NP-exposure of undifferentiated SH-SY5Y cells at 
DIV6 resulted in a significant increase in CHT1-expres-
sion when compared to the undifferentiated controls. 
In both, RA-control and RA-exposed to NPs, the CHT1 
expression was significantly lower than in undifferenti-
ated NP-exposed cells. Similar findings were obtained 
for ST-treated cells exposed to NPs at DIV6. A significant 
increase of CHT1-expression was observed in RA-con-
trol compared to ST-control cells (Fig. 5h).
Analysis of pathways involved in neurodifferentiation
Signaling pathways involved in neuronal differentiation, 
namely Akt and MAP-K (Fig.  6a, b) were studied after 
SiPCL-NP-exposure. The expression of the active phos-
phorylated form of Akt was increased in RA- and ST-
differentiated cells compared to undifferentiated controls 
Fig. 3 The effect of SiPCL‑NP‑exposure on tyrosine hydroxylase‑immunoreactive (TH‑ir) cell numbers was studied in SH‑SY5Y cells undifferentiated 
(Undiff ) or differentiated with retinoic acid (RA) or staurosporine (ST). SiPCL‑NPs were incubated for 24 h at day in vitro (DIV) 1 (A), DIV4 (B) or 
DIV6 (C) at a concentration of (2.6 × 1010 NPs/ml). The dopaminergic phenotype was analyzed at DIV7. The data represent TH‑ir cells and are given 
as mean percentage (%) of TH‑ir cells of the total number of cells. Error bars correspond to SEM. Significant differences between control‑ and 
NP‑exposed‑groups are labeled with asterisks (*p ≤ 0.001; **p ≤ 0.0001). Representative immunofluorescence microscopy images of TH‑ir cells (red) 
are depicted in D–F (D = Undiff NP DIV4, E = RA NP DIV4, F = ST NP DIV4). NPs are shown in red and cell nuclei in blue. Magnification ×630, scale 
bar = 10 μm
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but the effect was not statistically significant. SiPCL-
NPs-exposure did not change the expression of Akt in 
SH-SY5Y cells (Fig. 6a). The active phosphorylated forms 
of MAP-K, namely p42 and p44, were upregulated in RA-
differentiated controls (Fig.  6b). However, this upregu-
lation was only statistically significant for p42 MAP-K 
(11.5-fold; p ≤ 0.05). SiPCL-NP-exposure for 24  h at 
DIV4 (2.6 × 1010 NPs/ml) did not affect the expression of 
the active phospho-p42 and phospho-p44 MAP-K.
Expression of the maturity marker, i.e. microtubule-
associated protein 2 (MAP-2), was analyzed to esti-
mate the differentiation state depending on the time of 
NP-exposure (DIV1 in Fig.  7a; DIV4 in Fig.  7b, DIV6 
in Fig. 7c). Our data show an upregulation of MAP-2 in 
RA- and ST-differentiated cells compared to both undif-
ferentiated control SH-SY5Y cells, with the effect being 
statistically significant for the RA- and ST-controls and 
ST-differentiated and NP-exposed cells at DIV4 (Fig. 7b). 
MAP-2-expression was not significantly altered by expo-
sure to SiPCL-NPs at DIV4 for any differentiation sup-
plement investigated (Fig. 7b). No significant differences 
in MAP-2 expression were observed when NP-exposure 
was performed at DIV1 (Fig.  7a) and DIV6 (Fig.  7c) for 
all groups investigated. However, a tendency towards 
Fig. 4 SH‑SY5Y cells were exposed to SiPCL‑NP at a concentration of (2.6 × 1010 NPs/ml) for 24 h and cells displaying a cholinergic phenotype were 
analyzed. NP‑exposure was performed in undifferentiated cells (Undiff ) or cells differentiated with retinoic acid (RA) or staurosporine (ST) at day 
in vitro (DIV) 1 (A), DIV4 (B) or DIV6 (C). At the end of the differentiation period (DIV7), high‑affinity choline transporter 1‑immunoreactive (CHT1‑ir) 
cells were quantitatively assessed. Data represent the mean percentage (%) of CHT1‑ir cells of the total number of cells. Error bars correspond 
to SEM. Significant differences between control‑ and SiPCL‑NP‑exposed‑groups are labeled with asterisks (*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001). 
Representative immunofluorescence microscopy images of CHT1‑ir cells (green) are depicted in D–F (D = Undiff NP DIV4, E = RA NP DIV4, F = ST NP 
DIV4). NPs are shown in red and cell nuclei in blue. Magnification ×630, scale bar = 10 μm
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increased MAP-2 levels was seen for RA- and ST-differ-
entiated cells when compared to undifferentiated cells 
(Fig. 7a, c). An upregulation of activated (non-phospho-
rylated) β-catenin was obtained in RA-differentiated 
SH-SY5Y cells, but this effect was not statistically sig-
nificant, and β-catenin levels were not affected by SiPCL-
NP-exposure in undifferentiated, RA- and ST-treated 
SH-5YSY cells (Fig. 8A). β-catenin was found in or close 
to the cell membrane when analyzed by immunofluores-
cence microscopy. No apparent difference in the signal in 
undifferentiated and differentiated cells was obtained as 
illustrated in Fig. 8B–D. Furthermore, no co-localization 
of β-catenin and NPs was found (Fig. 8C, D). Differentia-
tion did not alter glycogen synthase kinase-3β (GSK-3β) 
expression in SH-SY5Y cells. A slight but non-significant 
increase in GSK-3β-expression was found after NP-expo-
sure in RA-differentiated cells, whereas the opposite was 
found after ST-differentiation (Fig. 8E). No variation was 
observed after NP-exposure in undifferentiated cells. 
GSK-3β was found in the cytoplasm with the signal being 
present in the entire cytoplasm (Fig. 8F–H). Microscopi-
cally, no obvious changes were noticed after SiPCL-NP-
exposure (Fig. 8F–H).
Discussion
RA-differentiated cells were most sensitive to SiPCL-
NPs before differentiation (NP-exposure on DIV1). ST-
differentiated SH-SY5Y cells were most impaired by NPs 
during differentiation (NP-exposure on DIV4). These 
findings might indicate that the NPs interfered with 
the mitochondrial activity of the cells at the beginning 
and during differentiation.  SiO2-NPs sized 20  nm were 
reported to lead to an inhibition of mitochondrial respir-
atory chain complexes, the mitochondrial dehydrogenase 
activity and the mitochondrial membrane potential in rat 
liver cells [39]. In rats, SiNP-exposure (sized 80 nm) was 
also shown to induce mitochondrial dysfunction in cells 
of the corpus striatum, and electron microscopic studies 
Fig. 5 Analyses of tyrosine hydroxylase (TH) (a–c), dopamine active transporter (DAT) (d–e) and the high‑affinity choline transporter 1 (CHT1) 
(f–h) were performed at day in vitro (DIV) 7 to evaluate the effect of SiPCL‑NP‑exposure for 24 h on DIV1 (a) and on DIV4 and DIV6 (b, c) on the 
phenotype of SH‑SY5Y cells. Undifferentiated cells (Undiff ) and cells differentiated with retinoic acid (RA) or staurosporine (ST) were investigated 
in parallel. Histograms depict the levels of TH, DAT and CHT1 in relation to the loading control (actin) given in arbitrary numbers. Representative 
Western blots are shown for DIV4 exposure above the respective histograms. Image J was used for the analysis. Error bars correspond to SEM. 
Significant differences between control‑ and NP‑exposed‑groups are labeled with asterisks (*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001)
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provided evidence of neuronal mitochondrial dysfunc-
tion after SiNP-exposure in rats [8]. We recently dem-
onstrated that SiPCL-NPs increased the mitochondrial 
membrane potential in SH-SY5Y cells under differentia-
tion [14]. Reactive oxygen species were found in undif-
ferentiated SH-SY5SY cells after exposure to PCL-NPs 
[12]. In agreement with our data, exposure to  TiO2NPs 
(15 μg/ml) for > 24 h was reported to decrease the viabil-
ity of SH-SY5Y cells by about 22% [40]. AgNP-exposure 
(16 and 32 μg/ml) for 24 h was also shown to reduce cell 
viability by 55% and 70% in undifferentiated SH-SY5Y 
[16]. In the neuron-like cell line PC12, a significant loss in 
cell viability was observed immediately after incubation 
with  SiO2-NP for 24 h. While the decrease in cell viability 
was comparable with our data, the NP-concentration 
was about 10-times higher (200 μg/ml) [10] and the zeta 
potential and the size of the NPs differed from those in 
our study [10, 16, 40]. As demonstrated before, size and 
zeta potential affect the toxicity of NPs [41]. In contrast, 
previously published studies using SiPCL-NPs demon-
strated no significant effect on cell viability in undiffer-
entiated and RA-differentiated SH-SY5Y cells [12] and 
rat primary hippocampal cells [23] after NP-exposure 
for 24  h. While the NP-concentrations remained the 
same, the methylthiazolyldiphenyl-tetrazolium bro-
mide (MTT)-based assay was used in this study, whereas 
Presto blue was used previously to analyze cell viability. 
There is evidence that mesoporous Si-NPs stimulated the 
Fig. 6 Analyses of differentiation markers [phosphatidylinositol‑3‑kinase (PI3‑K/Akt) and of mitogen‑activated‑protein‑kinase/extracellular‑signal‑r
egulated‑kinase (MAP‑K/ERK)] were performed at day in vitro (DIV) 7 to evaluate the effect of SiPCL‑NP‑exposure for 24 h on DIV4 in SH‑SY5Y cells. 
Undifferentiated cells (Undiff ) cells and cells differentiated with retinoic acid (RA) or staurosporine (ST) were assessed in parallel. Histograms (a, b) 
depict the ratio of phosphorylated Akt (P‑Akt) (a) and phosphorylated MAP‑K (P‑p42/44 MAP‑K) (b) to total Akt and p42/44 MAP‑K, respectively. 
Actin was used as a loading control. Representative Western blots are shown above the histograms. Image J was used for the analysis. Error bars 
correspond to SEM. Significant differences between control‑ and NP‑exposed‑groups are labeled with asterisks (*p ≤ 0.05)
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MTT formazan exocytosis in astrocytes and the MTT 
reduction test was shown to rather overestimate the cyto-
toxicity [42]. The tetrazolium-based MTT assay has long 
been regarded as the gold standard for cytotoxicity assays 
as it is highly sensitive, but it has been demonstrated to 
be less accurate in detecting changes in cell numbers [43]. 
Moreover, MTT-reduction was shown to be significantly 
affected by metabolic and energy perturbations. As meta-
bolic changes are known to occur during differentiation 
and NPs were shown to affect these changes [14, 44], an 
overestimation of the cytotoxicity is likely.
In accordance with this finding, previous studies using 
transmission electron microscopy (TEM) showed SiPCL-
NPs in the cytoplasm and intracellular vacuoles in RA-
differentiated SH-SY5Y cells [12]. Quantification of the 
NP-uptake revealed that 30% of the neurons had taken 
up SiPCL-NPs [23]. An uptake of Si-NPs has also been 
demonstrated in primary rat microglia using fluores-
cence microscopy and TEM [15]. However, it needs to 
be pointed out that the Si-NPs used in the present study 
where coated with PCL on the outside. Hence, the cells 
did not get in touch with the silica core of the NPs, which 
may also explain the different findings. Si-NPs have also 
been shown to infiltrate neuronal cell bodies and axonal 
projections of Drosophila melanogaster neurons and 
again, they have been found in the cytoplasm but not 
in the nucleus [11]. While astrocytes and neuronal stem 
cells were reported to take up Si-NPs, no uptake was 
seen in neurons [45]. Different coatings and NP-size as 
well as the cell type are known to affect the uptake of NPs 
[46–48]. Even though SiPCL-NPs were taken up by SH-
SY5Y cells, the cell morphology was not obviously altered 
in our experiments. Consistent with this finding, Ducray 
et  al. [14] demonstrated that SiPCL-NPs did not cause 
clear morphological alterations in SH-SY5Y cells. In the 
present study, the morphology of cholinergic and dopa-
minergic neurons was not affected by the NP-exposure.
In agreement with other studies, CHT1-ir cells were 
primarily seen in undifferentiated and RA-differentiated 
SH-SY5Y cells [49–51]. SiPCL-NPs decreased the num-
ber of cholinergic cells. Unlike the dopaminergic pheno-
type, this effect was found when the NPs were incubated 
before the differentiation, which might indicate that the 
cholinergic cells are more vulnerable in the beginning of 
the differentiation process, whereas the dopaminergic 
cells are more vulnerable towards the end.
Although SiPCL-NP-treatment in the middle of dif-
ferentiation did not result in a decrease of TH-ir cells in 
ST-differentiated cells, protein quantification revealed 
a decrease in the number of TH-positive cells after 
SiPCL-NPs-exposure. Similarly, a significant decrease in 
dopaminergic cells was also found when the SiPLC-NPs 
were added to the cells at the end of differentiation (NP-
exposure on DIV6), indicating that dopaminergic cells 
at the later state of differentiation might be more vul-
nerable to NP-exposure. However, the number of cells 
Fig. 7 Analysis of the neuronal marker microtubule‑associated 
protein 2 (MAP‑2) was performed at day in vitro (DIV) 7 to evaluate 
the effect of SiPCL‑NP‑exposure for 24 h at DIV1 (a) and DIV4 
(b) and DIV6 (c) on the state of differentiation in SH‑SY5Y cells. 
Undifferentiated cells (Undiff ) and cells differentiated with retinoic 
acid (RA) or staurosporine (ST) were examined in parallel. The 
histogram depicts MAP‑2 levels in relation to actin (loading control). A 
representative Western blot for SiPCL‑NP‑exposure on DIV4 is shown 
above the respective histogram. Image J was used for the analysis. 
Error bars correspond to SEM. Significant differences between 
control‑ and NP‑exposed‑groups are labeled with asterisks (*p ≤ 0.05; 
**p ≤ 0.01; ***p ≤ 0.001; ****p ≤ 0.0001)
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displaying the dopaminergic phenotype increased with 
time. Therefore, a difference in dopaminergic cells might 
be difficult to detect in the beginning and in the mid-
dle of the differentiation process. Consistent with these 
findings, the expression of TH was downregulated con-
centration-dependently in PC12 cells exposed to Si-NPs 
(25–200 μg/ml) for 24 h [10]. Corroborating our findings, 
a decrease in TH-expression was demonstrated after Si-
NP-exposure in other experimental models, namely in 
the substantia nigra of zebrafish [52], in olfactory bulb 
neurons of neonatal rats after treatment with nano-sized 
 TiO2 [53] and in the midbrain of rats after intracerebral 
injection of manganese-NPs [54]. On the other hand, 
an alteration of the dopaminergic marker DAT was not 
observed after exposure to SiPCL-NP. In agreement with 
this result, Si-NPs did not alter the expression of DAT in 
PC12 cells [10].
Dayem et  al. [22] also showed an increase in levels of 
phosphorylated-Akt and -ERK, proteins that have been 
demonstrated to play an important role in neurite elon-
gation (PI3-K/Akt), in neuronal survival and in synaptic 
plasticity (MAP-K/ERK) [27, 55, 56]. Primary astrocytes 
treated with ZnO-NPs were demonstrated to increase 
ERK- and MAP-K-phosphorylation (p38) [24]. In the pre-
sent study, key markers of signalling pathways involved in 
differentiation (pAKT and MAPK as well as GSK-3 and 
beta-catenin) were studied after SiPCL-NP-exposure at 
DIV4 because we hypothesized that significant changes 
in the respective phenotype may be accompanied by 
alterations of these markers. SiPCL-NPs did not change 
the expression of Akt and MAP-K regardless of the dif-
ferentiation supplement used. Ducray et al. [14] also did 
not observe an alteration in the expression of phospho-
rylated-Akt after SiPCL-exposure in RA-differentiated 
SH-SY5Y cells. A concentration-dependent decrease 
has also been reported for the active and phosphoryl-
ated forms of Akt and PI3K after  SiO2-NPs exposure 
in PC12 cells [28].  ZnO2-NPs with a size of 30  nm and 
45 nm and Ag-NPs were reported to activate the PI3K/
Akt- and MAP-K/ERK-pathway in primary astrocytes 
and SH-SY5Y cells, respectively [22, 24]. On the contrary, 
 SiO2-NPs, sized 25 nm and with a negative zeta potential 
(− 8.8  mV), exhibited adverse effects on the differentia-
tion of PC12 cells [28]. These results demonstrate again 
that physicochemical properties of NPs affect toxicity 
and uptake [47]. In contrast, MAP-2 was shown to be 
slightly upregulated after SiPCL-NP-treatment in SH-
SY5Y cells [14]. Ag-NP-exposure was demonstrated to 
significantly enhance the amount of mature neurons [22], 
which might be due to the different material of the NPs.
Markers involved in neuronal differentiation and neu-
rodegeneration, namely GSK-3β and β-catenin were not 
significantly altered by SiPCL-NPs in the present study 
regardless of the methods used. However, the NP-treat-
ment induced a slight increase of GSK-3β in RA-differen-
tiated cells, which might result in a subsequent depletion 
of β-catenin. In contrast, the non-significant downregu-
lation of GSK-3β in ST-differentiated cells is likely to 
prevent degradation of β-catenin and prevent neurode-
generation. As opposed to our results,  TiO2-NP-exposure 
was shown to increase the expression of GSK-3β and 
to downregulate β-catenin levels in primary rat hip-
pocampal neurons [33]. It is important to consider that 
an upregulation of GSK-3β is linked to degradation of 
β-catenin and alterations in this signaling cascade have 
been reported to be related to the pathogenesis of neuro-
degenerative diseases [57, 58].
Conclusions
The findings obtained from SiPCL-NP-exposure in 
SH-SY5Y cells undergoing differentiation indicate an 
impairment of the resulting dopaminergic and cholin-
ergic phenotype with the effect depending on the time 
of the NP-application during neuronal differentiation. 
The decrease in the number of cells representing the 
dopaminergic or the cholinergic phenotype may impli-
cate neuronal dysfunction, but the data do not provide 
evidence that pathways relevant for differentiation and 
related to neurodegeneration are impaired.
Methods
Cell culture
The human neuroblastoma cell line SH-SY5Y was pur-
chased from ATCC (Manassas, VA, USA) and cultured as 
reported previously [14]. For the experiments, SH-SY5Y 
cells of passage 5 to 21 at a confluency of 65–85% were 
used.
(See figure on next page.)
Fig. 8 Analyses of the Wnt‑pathway markers, β‑catenin and glycogen synthase kinase‑3 β (GSK‑3β), were performed at day in vitro (DIV) 7 to 
evaluate the effect of SiPCL‑NP‑exposure for 24 h on DIV4 in SH‑SY5Y cells. Undifferentiated cells (Undiff ) and cells differentiated with retinoic acid 
(RA) or staurosporine (ST) were examined in parallel. Histograms depict β‑catenin (A) and GSK‑3β (E) levels in relation to the loading control (actin). 
Representative Western blots are shown above the histograms. Image J was used for the analysis. Error bars correspond to SEM. Representative 
immunofluorescence microscopy images of β‑catenin‑stained cells (green) are depicted in B–D (B = Undiff NP DIV4, C = RA NP DIV4, D = ST NP 
DIV4) and GSK‑3β (green) in F–H (F = Undiff NP DIV4, G = RA NP DIV4, H = ST NP DIV4). NPs are shown in red and cell nuclei in blue. Magnification 
×630, scale bar = 10 μm
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The differentiation was carried out according to a pre-
viously published protocol with minor changes [14]. 
Briefly, the cells were seeded and kept in an undifferenti-
ated state for 24  h. For differentiation, plates and flasks 
were coated with poly-dl-lysine hydrobromide (0.1 mg/
ml) (96-well-plates, µClear® CELLSTAR ®, Greiner Bio-
One, AUT) or polyornithine 0.01%/laminin [6  μg/ml] 
(Sigma-Aldrich, Switzerland) on glass coverslips (VWR 
International, USA) (24-well-plates, Techno Plastic Prod-
ucts, Trasadingen, Switzerland). The differentiation pro-
cedure started at DIV 1. The protocol consisted of two 
phases of 3 days each. In phase one on DIV1, the differ-
entiation was induced by a 5% reduction of FBS in the 
medium and it was further reduced to 1% in phase two 
on DIV4. In both phases, the medium was supplemented 
with either RA at a concentration of 10  μM (Sigma-
Aldrich, Switzerland) or ST [5  nM] (Sigma-Aldrich, 
Switzerland). Undifferentiated controls were kept in the 
same medium for the entire culture period and medium 
changes were done at the same time point as for the dif-
ferentiated cells.
Nanoparticle exposure
SiPCL-NP synthesis, chemical and physical character-
istics were reported previously [6, 12, 14]. Briefly, the 
SiPCL-NPs had an average size of 80 nm and a negative 
Zeta potential of − 25.4 mV. Rhodamine-labeled SiPCL-
NPs were used for identification using fluorescence 
microscopy.
The NP-stock-solution was prepared at a concentration 
of 2.6 × 1011  NPs/ml in Dulbecco’s phosphate-buffered 
saline (Life Technologies, UK) with 0.25% dimethyl sul-
foxide (DMSO) (Sigma-Aldrich, Switzerland). Shortly 
before exposure to the cells, the NP-stock-solution 
was sonicated three times for 4 min with 4 min cooling 
steps between each sonication in order to prevent inho-
mogeneous distribution in the suspension as previously 
described [14]. NP-exposure was performed at a final 
concentration of 2.6 × 1010 NPs/ml in 1% FBS culture 
medium for 24 h either at the beginning, in the middle or 
at the end of the differentiation, i.e. on DIV1, DIV4 and 
DIV6, respectively. Cells devoid of SiPCL-NPs were used 
as controls throughout each in vitro assay.
Cell viability
Cell viability was measured spectrophotometrically 
using the methylthiazolyldiphenyl-tetrazolium bromide 
(MTT) colorimetric assay (Sigma-Aldrich, Switzerland) 
in control cells and the three groups exposed to NPs, 
namely cells exposed on DIV1, DIV4 and DIV6. SH-SY5Y 
cells were seeded in 96-well MICROTEST tissue cul-
ture plates (Falcon BD, USA) at a cell density of 8.4 × 103 
cells per well. On DIV7, three independent experiments 
were performed for each group. Briefly, MTT was added 
to the cells at a final concentration of 0.5  mg/ml. After 
incubation for four h at 37 °C in 5%  CO2, the precipitated 
formazan was dissolved in DMSO. Changes in absorb-
ance were measured with the Synergy H1 microplate 
reader (BioTek, USA) at a wavelength of 540 nm.
Phenotypical characterization
For phenotypical characterization, SH-SY5Y cells were 
seeded in 24-well tissue culture plates at a cell density 
of 2.8 × 104 cells per well. SiPCL-NP-exposure was per-
formed on DIV4. At DIV7, the cells were sequentially 
fixed in 2% and in 4% paraformaldehyde (Sigma-Aldrich, 
Switzerland) for 10  min each. Subsequently, the fixed 
cells were blocked for two h in 0.4% Triton-X (Sigma-
Aldrich, Switzerland) in phosphate-buffered saline (PBS) 
(Life Technologies, UK) with 10% horse serum (Thermo 
Fisher Scientific, Switzerland). The primary antibodies 
(see Table 1) were diluted in a stock solution (0.4% Tri-
ton-X PBS with 2.5% horse serum) and incubated with 
the cells overnight at 4  °C. The following day, the sec-
ondary antibodies (see Table 2) were diluted in the stock 
solution (see above). Hoechst 33,342 nucleic acid stain at 
a dilution of 1:10,000 (Thermo Fisher Scientific, Switzer-
land) was added and the cells were incubated for 2 h at 
room temperature in the dark. After mounting the cover 
slips on slides with Glycergel Mounting Medium (Agi-
lent Technologies, USA), immunofluorescence pictures 
were obtained with a Zeiss Axio Imager Z1 coupled with 
an Apotome 1 (Carl Zeiss Vision Swiss AG, Feldbach, 
Switzerland).
Table 1 Primary antibodies 
CHT1 choline transporter 1, DAT dopamine active transporter, GSK-3 β glycogen 
synthase kinase 3 β, IF immunofluorescence, MAP-2 microtubule associated 
protein 2, MAP-K mitogen activated protein kinase, TH tyrosine hydroxylase, WB 
western blot
Primary antibody Host Dilution Company
IF WB
phospho‑Akt Rabbit – 1:1000 Cell signaling
Akt Rabbit – 1:1000 Cell signaling
GSK‑3β Rabbit 1:400 1:1000 Cell signaling
TH Rabbit 1:500 1:1000 Cell signaling
β‑catenin Rabbit 1:400 1:500 Cell signaling
phospho‑p44/42 MAP‑K Mouse – 1:1000 Cell signaling
p44/42 MAP‑K Mouse – 1:1000 Cell signaling
CHT1 Mouse 1:250 1:500 Santa Cruz
β‑actin Mouse – 1:20,000 Sigma‑Aldrich
MAP‑2 Mouse – 1:500 Sigma‑Aldrich
β‑3‑tubulin Mouse 1:500 – Sigma‑Aldrich
α/β‑synuclein Mouse 1:250 – Santa Cruz
DAT Rat – 1:1000 Millipore
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Quantification of cellular phenotype
Quantification of dopaminergic and cholinergic pheno-
types was performed using high-content analysis in con-
trol cells and cells exposed to SiPCL-NPs on DIV1, DIV4 
and DIV6. The SH-SY5Y cells were seeded in a 96-well 
microplate at a cell density of 8.4 × 103 cells per well. 
On DIV7, the cells were fixed and blocked as described 
above. The primary antibodies against TH and CHT1 
(see Table 1) were diluted in a stock solution consisting of 
0.4% Triton-X PBS with 2.5% horse serum, and the incu-
bations with the cells were performed overnight at 4 °C.
As described above, the secondary antibodies (Table 2) 
were applied together with Hoechst 33342 nucleic acid 
stain on the following day. For the quantitative analy-
sis of TH- ir and CHT1-ir cells, high content analysis of 
the SH-SY5Y cells was performed with an INCell Ana-
lyzer 2000 (INCA) (General Electric Healthcare Europe 
GmbH, Glattbrugg, Switzerland).
Images were taken from three wells per group and 35 
randomly assigned areas for each well. The total number 
of cells, evaluated by the number of nuclei, and TH- or 
CHT1-ir cells were determined using the INCell Devel-
oper Toolbox  1.9.2 (General Electric Healthcare Europe 
GmbH, Glattbrugg, Switzerland).
Analysis of markers involved in neuronal differentiation
Markers of pathways involved in neuronal differentia-
tion, namely Akt, MAP-K, GSK-3β, β-catenin, MAP-2, 
TH, DAT, and CHT1, were studied after SiPCL-NP-
exposure at DIV1, 4 and 6. SH-SY5Y cells were seeded 
in a 75  cm2 tissue culture flask (Techno Plastic Prod-
ucts, Trasadingen, Switzerland) at a cell density of 
1.3–1.4 × 106 cells per flask before differentiation and 
exposure to SiPCL-NPs (DIV4). On DIV7, total cellu-
lar protein was extracted using cold protein lysis buffer 
containing phosphatase (Sigma-Aldrich, Switzerland) 
and protease (Thermo Fisher Scientific, Switzerland) 
cocktail inhibitors. Protein (10  μg) from each sam-
ple was loaded and separated on 10% SDS-Page gels. 
Thereafter, the transfer from the gel to a polyvinylidene 
difluoride membrane (Bio-Rad Laboratories, USA) or 
a nitrocellulose membrane (GE Healthcare Life sci-
ence, UK) was performed. Blocking of the membranes 
was accomplished with the stock solution contain-
ing 0.2% TWEEN 20 (Sigma-Aldrich, Switzerland) in 
PBS with 5% milk powder for two h. Incubations with 
the primary antibodies (see Table  1) were performed 
overnight at 4  °C in the stock solution. Finally, the 
membranes were incubated for 2  h in the stock solu-
tion with the corresponding horseradish peroxidase 
(HRP) conjugated secondary antibody (see Table  2). 
The bands were detected using chemiluminescent 
substrate (Advansta Western Bright Sirius Chemilu-
minescent, Witec, Switzerland) and a CCD-LAS3000 
camera (Fujifilm, Japan). The blots were quantified with 
ImageJ analysis (National Institutes of Health, USA) 
using arbitrary units to determine the ratio between the 
band-intensity of the respective marker and the corre-
sponding band of actin.
Statistical analysis
For each experiment, at least three independent experi-
ments were performed. Statistical analysis was carried 
out with GraphPad Prism 6 (GraphPad Software Inc., 
USA). Student’s unpaired t-test was used to analyze cell 
viability, TH- and CHT1-ir cells in SiPCL-NP-exposed 
and control cultures. A one-way ANOVA test followed 
by Tukey’s multiple comparison test was used for the 
analysis of differentiation and neuronal markers. The 
results are presented by mean ± standard error of the 
mean (SEM). P-values of ≤ 0.05 were considered as sta-
tistically significant.
Table 2 Antibodies
AF Alexa Fluor, dk donkey, HRP horseradish peroxidase, IF immunofluorescence, WB Western blot
Secondary antibody Dilution Use with corresponding primary for detection of Company
IF WB
dk anti‑rabbit IgG HRP – 1:5000 phospho‑Akt; Akt; TH Novex
– 1:10,000 GSK3‑b; β‑catenin
dk anti‑rabbit IgG
AF 488 or 647 nm
1:200 – GSK3‑b; β‑catenin; TH Invitrogen




1:200 – CHT1; β‑3‑tubulin; α/β‑synuclein Invitrogen
dk anti‑rat IgG HRP – 1:2000 DAT Novex
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